Release Date: 24/05/21 16:19 Summary: Change of Director's Interest Notice Price Sensitive: No Download Document 202.89KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%